BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 9806632)

  • 1. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected].
    Boniface JJ; Rabinowitz JD; Wülfing C; Hampl J; Reich Z; Altman JD; Kantor RM; Beeson C; McConnell HM; Davis MM
    Immunity; 1998 Oct; 9(4):459-66. PubMed ID: 9806632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
    Stone JD; Stern LJ
    J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events.
    Itoh Y; Hemmer B; Martin R; Germain RN
    J Immunol; 1999 Feb; 162(4):2073-80. PubMed ID: 9973480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-step binding mechanism for T-cell receptor recognition of peptide MHC.
    Wu LC; Tuot DS; Lyons DS; Garcia KC; Davis MM
    Nature; 2002 Aug; 418(6897):552-6. PubMed ID: 12152083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 expression allows T cell signaling by monomeric peptide-MHC complexes.
    Delon J; Grégoire C; Malissen B; Darche S; Lemaître F; Kourilsky P; Abastado JP; Trautmann A
    Immunity; 1998 Oct; 9(4):467-73. PubMed ID: 9806633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy).
    Candia M; Kratzer B; Pickl WF
    Int Arch Allergy Immunol; 2016; 170(4):211-233. PubMed ID: 27642756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A window of opportunity for cooperativity in the T Cell Receptor.
    Martin-Blanco N; Blanco R; Alda-Catalinas C; Bovolenta ER; Oeste CL; Palmer E; Schamel WW; Lythe G; Molina-París C; Castro M; Alarcon B
    Nat Commun; 2018 Jul; 9(1):2618. PubMed ID: 29976994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular components of T-cell recognition.
    Jorgensen JL; Reay PA; Ehrich EW; Davis MM
    Annu Rev Immunol; 1992; 10():835-73. PubMed ID: 1591005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation.
    Wang C; Mooney JL; Meza-Romero R; Chou YK; Huan J; Vandenbark AA; Offner H; Burrows GG
    J Immunol; 2003 Aug; 171(4):1934-40. PubMed ID: 12902496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognate peptide-MHC complexes are expressed as tightly apposed nanoclusters in virus-infected cells to allow TCR crosslinking.
    Ferez M; Castro M; Alarcon B; van Santen HM
    J Immunol; 2014 Jan; 192(1):52-8. PubMed ID: 24307729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.
    Yasutomo K; Lucas B; Germain RN
    J Immunol; 2000 Sep; 165(6):3015-22. PubMed ID: 10975810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
    Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
    J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
    Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
    J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
    Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
    Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatically mediated engineering of multivalent MHC class II-peptide chimeras.
    Casares S; Bona CA; Brumeanu TD
    Protein Eng; 2001 Mar; 14(3):195-200. PubMed ID: 11342717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stimulatory potency of T cell antigens is influenced by the formation of the immunological synapse.
    Cemerski S; Das J; Locasale J; Arnold P; Giurisato E; Markiewicz MA; Fremont D; Allen PM; Chakraborty AK; Shaw AS
    Immunity; 2007 Mar; 26(3):345-55. PubMed ID: 17346997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands.
    Madrenas J; Chau LA; Smith J; Bluestone JA; Germain RN
    J Exp Med; 1997 Jan; 185(2):219-29. PubMed ID: 9016871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the stochastic sequence of individual ligand-receptor binding events to cellular activation: T cells act on the rare events.
    Lin JJY; Low-Nam ST; Alfieri KN; McAffee DB; Fay NC; Groves JT
    Sci Signal; 2019 Jan; 12(564):. PubMed ID: 30647147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation.
    Germain RN; Stefanová I
    Annu Rev Immunol; 1999; 17():467-522. PubMed ID: 10358766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.
    Racioppi L; Ronchese F; Matis LA; Germain RN
    J Exp Med; 1993 Apr; 177(4):1047-60. PubMed ID: 8384651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.